Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Granted 33,000 inducement options to one new hire at $0.72 strike, vesting over four years; routine Nasdaq 5635(c)(4) disclosure.
What this release says
Milestone Pharmaceuticals granted 33,000 stock options to one newly hired employee as an inducement to join, under Nasdaq's rule for hiring grants. The options carry an exercise price of $0.72 per share, equal to the closing price on the grant date of November 2, 2026. For a shareholder, this is a small, routine grant that adds potential future share issuance without any change to current operations or capital.
Key figures
- Options granted
- 33,000 options
- Exercise price
- $0.72 per share
- Grant date
- November 2, 2026
- Initial vesting
- 25% after one year
- Remaining vesting
- 36 monthly installments
Positive for shareholders
- The exercise price equals the closing price on the grant date, so the employee only benefits if the share price rises.
Negative for shareholders
- The options add potential future share issuance, which could dilute existing holders if exercised.
Written by Quantisnow AI from this release. Not financial advice.
Key terms
- Inducement grant:
- An equity award given to a new hire as an incentive to accept a job, allowed outside the standard employee plan under Nasdaq rules.
- Exercise price:
- The fixed price at which an option holder can buy a share, regardless of the market price later.
- Vest:
- To earn the right to exercise an option, usually over time and subject to continued employment.
FAQ
What did Milestone Pharmaceuticals grant in this release?
The company granted 33,000 options to purchase its common shares to one new employee under its 2021 Inducement Plan.
When do the options vest?
25% vest on the one-year anniversary of the vesting commencement date, and the remainder vest in 36 equal monthly installments after that.
Historical context for MIST
Across the 28 sessions after earlier MIST headlines, the stock closed higher 14 times and lower 13 times, with a median move of 2.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2019
Follow MIST and get a push notification the moment its next story breaks.